•  
  •  
  •  
  •  

2025-12-23 12:20:40

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE0HV901016

Stock Report

  • AbhiBus partners with OSRTC to Expand State Transport Bus Coverage in Odisha
  • ixigo Partners with CRED to Power Flight Bookings for the Newly Launched CRED IndusInd Bank RuPay Credit Card
  • AbhiBus expands SRTC Partnerships, Now Offering 17 State Road Transport Services Across India
  • AbhiBus and CheckMyBus announce partnership to expand Global Access to India's Bus Network
  • AbhiBus becomes the Official Bus Travel Partner of Chennai Super Kings for the T20 Season 2025
  • ixigo announces APRIL FULL REFUND SALE for 1st April - 100 Lucky Travellers To Win 100% Refund on Flight Bookings
  • ConfirmTkt Renews Partnership with Royal Challengers Bengaluru as the Official Train Ticketing Partner for T20 Season 2025
  • ixigo Launches 'Travel Guarantee' - Offering 3X Refund on Unconfirmed Waitlisted Train Tickets
  • ixigo Trains Onboards Cricket Icon Rohit Sharma as Brand Ambassador
  • ixigo Launches 'Price Lock' for Flights: Lock Fare Now, Book Later
  • FlixBus, Europe's Largest Intercity Bus Service, Partners with AbhiBus to Expand its Reach in India
  • ixigo Expands Exclusive Partnership With PhonePe to Flight, Bus & Train Bookings

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024